Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine vs Memantine for Paclitaxel-Induced Peripheral Neuropathy
NCT04737967Phase 3Unknown
- Sponsor
- Mendel AI
- Start
- Feb 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of venlafaxine, memantine in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Mendel AI. Status: unknown.
02
Drugs
venlafaxinememantine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT04737967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04737967.